医学
内科学
淋巴瘤
外周T细胞淋巴瘤
国际预后指标
胃肠病学
B症状
纵隔淋巴结病
危险系数
比例危险模型
血管免疫母细胞性T细胞淋巴瘤
未另行规定
病理
T细胞
活检
弥漫性大B细胞淋巴瘤
免疫学
免疫系统
置信区间
作者
Dai Chihara,Yasuhiro Oki,Shouji Ine,Kazuhito Yamamoto,Harumi Kato,Hirofumi Taji,Yoshitoyo Kagami,Yasushi Yatabe,Shigeo Nakamura,Yasuo Morishima
标识
DOI:10.3109/10428190903318311
摘要
We evaluated multiple patient characteristics for their prognostic significance in patients with peripheral T-cell lymphoma (angioimmunoblastic T-cell lymphoma [AITL; n = 31] and peripheral T-cell lymphoma, not otherwise unspecified [PTCL-NOS; n = 37]). Five-year overall survival (OS) rates in AITL and PTCL-NOS were 49% and 45%, respectively (p = 0.89). Cox proportional hazard model revealed that male sex, hemoglobin <10.0 g/dL and performance status (PS) > or =2 were independently associated with shorter OS in AITL. In patients with PTCL-NOS, low albumin, PS > or = 2, and mediastinal lymphadenopathy were independently associated with worse OS. When analysis in PTCL-NOS was performed incorporating Prognostic Index for PTCLu (PIT), low albumin and mediastinal lymphadenopathy were still both prognostic for OS. Three-year progression free survival (PFS) rates in AITL and PTCL-NOS were 49% and 47%, respectively (p = 0.578). None of the parameters was significantly associated with shorter PFS in AITL. In patients with PTCL-NOS, PS > or = 2 and mediastinal lymphadenopathy were independently associated with shorter PFS. The result is in keeping with previous large scale studies. Besides, we showed the potential prognostic importance of albumin and mediastinal lymphadenopathy in patients with PTCL-NOS.
科研通智能强力驱动
Strongly Powered by AbleSci AI